Search
St. John's Wort
go.drugbank.com/drugs/DB01323ApprovedInvestigationalNutraceuticalCategories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeAminocaproic acid
go.drugbank.com/drugs/DB00513ApprovedInvestigationalAn antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
Maplirpacept
go.drugbank.com/drugs/DB18441InvestigationalMaplirpacept is a recombinant fusion protein consisting of the CD47-binding domain of human signal regulatory protein alpha (SIRPa) linked to the IgG4 Fc region of human IgG.
Chlorophetanol
go.drugbank.com/drugs/DB11368ExperimentalChlorophetanol is an agent known to have antifungal activities.
Trapidil
go.drugbank.com/drugs/DB09283ExperimentalTrapidil, a platelet-derived growth factor antagonist, was originally developed as a vasodilator and anti-platelet agent and has been used to treat patients with ischemic coronary heart, liver, and kidney
Zinc picolinate
go.drugbank.com/drugs/DB11175InvestigationalIt is available as OTC dietary supplements as a source of zinc to treat and prevent zinc deficiency. The absorption of zinc after oral administration of zinc picolinate is shown to be effective.
Phosmet
go.drugbank.com/drugs/DB11448ExperimentalVet approvedIt is mainly used on apple trees to control codling moths. It is also used on other fruit crops, ornamentals, and vines to control aphids, suckers, mites, and fruit flies.
Synonyms: O,O-Dimethyl phthalimidomethyl phosphorodithioate, O,O-Dimethyl S-(phthalimidomethyl) dithiophosphateSinefungin
go.drugbank.com/drugs/DB01910ExperimentalThis compound belongs to the purine nucleosides and analogues. These are compounds comprising a purine base attached to a sugar.
5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole
go.drugbank.com/drugs/DB08720ExperimentalThis compound belongs to the phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. This drug is known to target genome polyprotein.
Farletuzumab ecteribulin
go.drugbank.com/drugs/DB18857InvestigationalFarletuzumab ecteribulin is under investigation in clinical trial NCT04300556 (A Study to Evaluate the Safety, Tolerability, and Efficacy of Morab-202 (Herein Referred to as Farletuzumab Ecteribulin),